Hepatitis D Virus-Specific CD8


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
05 2019
Historique:
received: 15 08 2018
revised: 08 01 2019
accepted: 15 01 2019
pubmed: 22 1 2019
medline: 14 5 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

Hepatitis D virus (HDV) superinfection of patients with chronic HBV infection results in rapid progression to liver cirrhosis. Little is known about HDV-specific T cells and how they contribute to the antiviral immune response and liver disease pathogenesis. We isolated peripheral blood mononuclear cells from 28 patients with chronic HDV and HBV infection, identified HDV-specific CD8 We identified 6 CD8 CD8

Sections du résumé

BACKGROUND & AIM
Hepatitis D virus (HDV) superinfection of patients with chronic HBV infection results in rapid progression to liver cirrhosis. Little is known about HDV-specific T cells and how they contribute to the antiviral immune response and liver disease pathogenesis.
METHODS
We isolated peripheral blood mononuclear cells from 28 patients with chronic HDV and HBV infection, identified HDV-specific CD8
RESULTS
We identified 6 CD8
CONCLUSIONS
CD8

Identifiants

pubmed: 30664876
pii: S0016-5085(19)30095-2
doi: 10.1053/j.gastro.2019.01.035
pmc: PMC7367679
mid: NIHMS1519072
pii:
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
HLA-A Antigens 0
HLA-B Antigens 0
Hepatitis delta Antigens 0
Interleukin-7 Receptor alpha Subunit 0
PDCD1 protein, human 0
Peptides 0
Programmed Cell Death 1 Receptor 0
Interferon-gamma 82115-62-6

Banques de données

ClinicalTrials.gov
['NCT02511431', 'NCT00023322', 'NCT01495585', 'NCT00001971']

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1805-1819.e9

Subventions

Organisme : Intramural NIH HHS
ID : Z01 DK054509
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 DK054516
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DK054508
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DK054509
Pays : United States

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Références

J Immunol. 2002 Sep 15;169(6):3447-58
pubmed: 12218168
Curr Protoc Immunol. 2013 Feb;Chapter 18:Unit 18.3.
pubmed: 23392640
Immunity. 2010 Aug 27;33(2):229-40
pubmed: 20727791
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9777-82
pubmed: 20457902
J Clin Invest. 1997 Aug 1;100(3):503-13
pubmed: 9239396
Arch Virol. 2012 Apr;157(4):647-59
pubmed: 22241621
J Hepatol. 2015 Jul;63(1):13-9
pubmed: 25646888
Immunity. 2016 Aug 16;45(2):415-27
pubmed: 27533016
J Virol. 2015 Jan;89(1):703-12
pubmed: 25355876
J Exp Med. 2000 Apr 17;191(8):1269-80
pubmed: 10770795
J Immunol. 2013 Apr 1;190(7):3207-15
pubmed: 23455505
J Immunol. 2006 Feb 1;176(3):1439-46
pubmed: 16424171
Blood. 2008 Jun 1;111(11):5326-33
pubmed: 18276844
J Immunol. 1994 Dec 15;153(12):5586-92
pubmed: 7527444
J Virol. 2018 Jun 13;92(13):
pubmed: 29669837
J Immunol. 1991 Oct 15;147(8):2663-9
pubmed: 1717570
Cytometry A. 2011 Feb;79(2):167-74
pubmed: 21265010
J Immunol. 2007 Jun 15;178(12):7890-901
pubmed: 17548627
Nat Commun. 2017 May 03;8:15050
pubmed: 28466857
J Virol. 1997 Mar;71(3):2241-51
pubmed: 9032359
J Hepatol. 2016 Apr;64(1 Suppl):S102-S116
pubmed: 27084031
Hepatology. 2018 Apr;67(4):1224-1236
pubmed: 29152762
Lancet Infect Dis. 2015 Oct;15(10):1167-1174
pubmed: 26189433
Virus Genes. 2005 May;30(3):383-93
pubmed: 15830157
J Immunol. 2010 Feb 1;184(3):1191-9
pubmed: 20026746
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7149-53
pubmed: 1496009
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
Science. 1992 May 29;256(5061):1331-3
pubmed: 1598578
J Gen Virol. 2004 Oct;85(Pt 10):3089-3098
pubmed: 15448372
J Infect Dis. 2017 Jan 1;215(1):139-149
pubmed: 27803174
Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):580-9
pubmed: 27534692
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8774-8
pubmed: 2430299
Ann Intern Med. 1983 Apr;98(4):437-41
pubmed: 6340574

Auteurs

Helenie Kefalakes (H)

Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.

Christopher Koh (C)

Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.

John Sidney (J)

La Jolla Institute of Immunology, La Jolla, California.

Georgios Amanakis (G)

Laboratory of Cardiac Physiology, Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.

Alessandro Sette (A)

La Jolla Institute of Immunology, La Jolla, California.

Theo Heller (T)

Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland.

Barbara Rehermann (B)

Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland. Electronic address: Rehermann@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH